Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

NCT03210246 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Trial ,Phase I

Interventions

DRUG: Vilaprisan (BAY 1002670)
DRUG: Vilaprisan Placebo
DRUG: Microgynon
DRUG: Microgynon Placebo

Sponsor

Bayer